Scholarlink

<p>Gamma entrainment shows promise for Alzheimer’s disease (AD) treatment in preclinical models, but human trials have yielded heterogeneous results. We hypothesized that the clinical efficacy of gamma entrainment depends on individual neurophysiological receptivity, specifically the capacity for neural circuit plasticity. In this open-label pilot study, we screened 37 individuals and enrolled 16 participants with early AD (CDR 0.5–1.0, amyloid-positive) who completed 12&#xa0;weeks of home-based flickering light stimulation at individually optimized gamma frequencies (32–40&#xa0;Hz). Pre- and post-intervention assessments included 64-channel EEG recordings and MMSE. Participants demonstrated dichotomous neurophysiological responses: 43.8% showed center frequency (CF) increase (increased CF [ICF+]) while 56.3% showed no change/decrease (non-increased CF [ICF−]). CF restoration was significantly associated with cognitive preservation (<i>r</i> = 0.52, <i>p</i> = 0.039). Notably, future responders exhibited distinct baseline signatures of “neural reserve,” characterized by higher temporal gamma power (Cohen’s <i>d</i> = 0.70–0.92) and stronger frontotemporal connectivity (Cohen’s <i>d</i> = 1.11–1.47). Almost 30% of screened candidates failed to show baseline entrainment, highlighting a distinct “non-responsive” biological subtype. CF restoration following personalized gamma entrainment identifies a neurophysiological subtype capable of meaningful plasticity. Rather than a universal remedy, gamma entrainment appears to act on specific neural substrates preserved in a subset of patients. These findings suggest that baseline electrophysiological profiling could unlock gamma entrainment’s therapeutic potential by stratifying likely responders for precision neuromodulation.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Restoration of gamma center frequency via personalized entrainment marks cognitive preservation in early Alzheimer’s disease

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月10日

查看全文
  • Yeseung Park,
  • Hyeonwook Chae,
  • Euisuk Yoon,
  • Yejung Kim,
  • Ji Won Han,
  • Se Joon Woo,
  • Seunghyup Yoo,
  • Ki Woong Kim

摘要

Gamma entrainment shows promise for Alzheimer’s disease (AD) treatment in preclinical models, but human trials have yielded heterogeneous results. We hypothesized that the clinical efficacy of gamma entrainment depends on individual neurophysiological receptivity, specifically the capacity for neural circuit plasticity. In this open-label pilot study, we screened 37 individuals and enrolled 16 participants with early AD (CDR 0.5–1.0, amyloid-positive) who completed 12 weeks of home-based flickering light stimulation at individually optimized gamma frequencies (32–40 Hz). Pre- and post-intervention assessments included 64-channel EEG recordings and MMSE. Participants demonstrated dichotomous neurophysiological responses: 43.8% showed center frequency (CF) increase (increased CF [ICF+]) while 56.3% showed no change/decrease (non-increased CF [ICF−]). CF restoration was significantly associated with cognitive preservation (r = 0.52, p = 0.039). Notably, future responders exhibited distinct baseline signatures of “neural reserve,” characterized by higher temporal gamma power (Cohen’s d = 0.70–0.92) and stronger frontotemporal connectivity (Cohen’s d = 1.11–1.47). Almost 30% of screened candidates failed to show baseline entrainment, highlighting a distinct “non-responsive” biological subtype. CF restoration following personalized gamma entrainment identifies a neurophysiological subtype capable of meaningful plasticity. Rather than a universal remedy, gamma entrainment appears to act on specific neural substrates preserved in a subset of patients. These findings suggest that baseline electrophysiological profiling could unlock gamma entrainment’s therapeutic potential by stratifying likely responders for precision neuromodulation.